ASX - By Stock
|
SNT |
Re:
Ann: Boehringer discontinues development of BI 1467335 for NASH
|
|
Blockbuster
|
40 |
26K |
1 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
40
|
26K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Boehringer discontinues development of BI 1467335 for NASH
|
|
Blockbuster
|
40 |
26K |
1 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
40
|
26K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
2 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
0 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
0 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
2 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
1 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
0 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
0 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
Blockbuster
|
29 |
21K |
2 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
29
|
21K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Boehringer discontinues development of BI 1467335 for NASH
|
|
Blockbuster
|
40 |
26K |
1 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
40
|
26K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Boehringer discontinues development of BI 1467335 for NASH
|
|
Blockbuster
|
40 |
26K |
1 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
40
|
26K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Business Plan Update
|
|
Blockbuster
|
1 |
2.4K |
2 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
1
|
2.4K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
4 |
13/12/19 |
13/12/19 |
ASX - By Stock
|
42
|
19K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: AGM Presentation 2019
|
|
Blockbuster
|
76 |
31K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
76
|
31K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
2 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
42
|
19K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
5 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
20
|
14K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
2 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
42
|
19K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
4 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
20
|
14K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
4 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
20
|
14K
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
Blockbuster
|
5.9K |
2.3M |
6 |
20/11/19 |
20/11/19 |
Charts
|
5.9K
|
2.3M
|
6
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
1 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
20
|
14K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
3 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
20
|
14K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
2 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
42
|
19K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Blockbuster
|
39 |
18K |
0 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
39
|
18K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
3 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
42
|
19K
|
3
|
|
ASX - By Stock
|
SNT |
NASH Phase 2 results imminent --A $20+ BILLION Market
|
|
Blockbuster
|
42 |
19K |
2 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
42
|
19K
|
2
|
|
Charts
|
PER |
Re:
Chart
|
|
Blockbuster
|
5.9K |
2.3M |
1 |
08/11/19 |
08/11/19 |
Charts
|
5.9K
|
2.3M
|
1
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
0 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
20
|
14K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change in substantial holding from AEF
|
|
Blockbuster
|
24 |
13K |
6 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
24
|
13K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
2 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
20
|
14K
|
2
|
|
ASX - By Stock
|
SNT |
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem
|
|
Blockbuster
|
20 |
14K |
4 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
20
|
14K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
9 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
595
|
349K
|
9
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
221K |
6 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
302
|
221K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Some Antisense Deal Numbers
|
|
Blockbuster
|
12 |
6.4K |
3 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
12
|
6.4K
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
Blockbuster
|
5.9K |
2.3M |
11 |
08/10/19 |
08/10/19 |
Charts
|
5.9K
|
2.3M
|
11
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
221K |
6 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
302
|
221K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
5 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
595
|
349K
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
Blockbuster
|
5.9K |
2.3M |
12 |
07/10/19 |
07/10/19 |
Charts
|
5.9K
|
2.3M
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
10 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
595
|
349K
|
10
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
221K |
11 |
07/10/19 |
07/10/19 |
ASX - By Stock
|
302
|
221K
|
11
|
|
Charts
|
PER |
Re:
Chart
|
|
Blockbuster
|
5.9K |
2.3M |
8 |
07/10/19 |
07/10/19 |
Charts
|
5.9K
|
2.3M
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
9 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
8 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
7 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
5 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
2 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
1 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
349K |
3 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
595
|
349K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
221K |
1 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
302
|
221K
|
1
|
|